Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:NESV OTCMKTS:PBIO NASDAQ:SPEC NASDAQ:TBIO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNESVNational Automation Services$0.00$0.00▼$0.00$6K-1.8349,150 shs1 shsPBIOPressure BioSciences$0.00-66.7%$0.00$0.00▼$0.21N/A-0.88321 shs401 shsSPECSpectaire$0.00$0.00$0.00▼$0.40$6K-6.2813,743 shsN/ATBIOTelesis Bio$0.02$0.11$0.01▼$6.17$40K2.896,394 shs4 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNESVNational Automation Services0.00%0.00%0.00%0.00%0.00%PBIOPressure BioSciences0.00%-66.67%-95.45%-96.77%-99.33%SPECSpectaire0.00%0.00%-72.73%-72.73%-99.91%TBIOTelesis Bio0.00%0.00%-92.67%-95.51%-99.44%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNESVNational Automation ServicesN/AN/AN/AN/AN/AN/AN/AN/APBIOPressure BioSciencesN/AN/AN/AN/AN/AN/AN/AN/ASPECSpectaireN/AN/AN/AN/AN/AN/AN/AN/ATBIOTelesis BioN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNESVNational Automation Services 0.00N/AN/AN/APBIOPressure BioSciences 0.00N/AN/AN/ASPECSpectaire 0.00N/AN/AN/ATBIOTelesis Bio 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNESVNational Automation ServicesN/AN/AN/AN/AN/AN/APBIOPressure BioSciences$1.98M0.00N/AN/A($1.29) per share0.00SPECSpectaireN/AN/AN/AN/A($1.77) per shareN/ATBIOTelesis Bio$225.09M0.00N/AN/A$0.14 per share0.16Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNESVNational Automation ServicesN/AN/A0.00N/AN/AN/AN/AN/AN/APBIOPressure BioSciences-$29.31M-$0.96N/A∞N/AN/AN/AN/AN/ASPECSpectaire$8.95MN/A0.00∞N/AN/A-81.22%304.57%N/ATBIOTelesis Bio-$47.72M-$28.20N/A∞N/A-336.59%N/A-61.89%8/5/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNESVNational Automation ServicesN/AN/AN/AN/AN/APBIOPressure BioSciencesN/AN/AN/AN/AN/ASPECSpectaireN/AN/AN/AN/AN/ATBIOTelesis BioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNESVNational Automation ServicesN/AN/AN/APBIOPressure BioSciencesN/AN/AN/ASPECSpectaireN/A0.030.02TBIOTelesis BioN/A1.231.06Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNESVNational Automation ServicesN/APBIOPressure BioSciences0.02%SPECSpectaire26.55%TBIOTelesis Bio37.63%Insider OwnershipCompanyInsider OwnershipNESVNational Automation Services30.90%PBIOPressure BioSciences10.80%SPECSpectaire25.40%TBIOTelesis Bio24.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNESVNational Automation ServicesN/A61.31 millionN/ANot OptionablePBIOPressure BioSciences1042.97 million38.33 millionNot OptionableSPECSpectaire818.41 million13.74 millionNot OptionableTBIOTelesis Bio2001.80 million1.36 millionOptionablePBIO, TBIO, NESV, and SPEC HeadlinesRecent News About These CompaniesTelesis Bio Inc (TBIO) Stock Forums - Investing.comJune 29, 2025 | investing.comTelesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene SynthesisMay 28, 2025 | finance.yahoo.comTelesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA SynthesisMarch 20, 2025 | finance.yahoo.comTelesis Bio: Q3 Earnings SnapshotNovember 8, 2024 | timesunion.comTTelesis Bio Announces Departure of Chief Legal OfficerOctober 25, 2024 | markets.businessinsider.comTelesis Bio Shares Double After News of Beckman Coulter Life Sciences CollaborationSeptember 27, 2024 | marketwatch.comWhat's Going On With Telesis Bio Shares Thursday?September 27, 2024 | msn.comTelesis Bio Inc (TBIO) Stock: More Strategic Than Meets the EyeSeptember 27, 2024 | bovnews.comBTelesis Bio Stock Is Soaring Wednesday: What's Going On?September 26, 2024 | msn.comTelesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA SynthesisSeptember 25, 2024 | globenewswire.comThe TBIO Conundrum: Why Telesis Bio Inc’s Stock Is Making Headlines AgainSeptember 21, 2024 | bovnews.comBTelesis Bio Inc (TBIO) Stock: Greater Than Its Current Valuation?September 19, 2024 | bovnews.comBTelesis Bio Plans to Delist its Securities from The Nasdaq Stock MarketSeptember 10, 2024 | globenewswire.comTelesis Bio Names CEO Eric Esser as Chair After Five Board Members ResignAugust 30, 2024 | marketwatch.comTelesis Bio IncAugust 15, 2024 | money.usnews.comTBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q2 2024August 7, 2024 | msn.comTelesis Bio Reports Second Quarter and First Half 2024 Financial ResultsAugust 7, 2024 | finance.yahoo.comTelesis Bio (NASDAQ:TBIO) Stock, Short Interest ReportJuly 31, 2024 | benzinga.comTBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q1 2024May 10, 2024 | investorplace.comTelesis Bio Reports First Quarter 2024 Financial ResultsMay 9, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military Spend3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonHow a Government Loan Changes the Game for Plug PowerBy Jeffrey Neal Johnson | July 4, 2025View How a Government Loan Changes the Game for Plug PowerAmerica Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025View America Wants Drone Dominance: Are These Stocks Ready to Soar?Nebius Group: Up 385%, Analysts Say It’s Still a BargainBy Jeffrey Neal Johnson | July 10, 2025View Nebius Group: Up 385%, Analysts Say It’s Still a BargainPBIO, TBIO, NESV, and SPEC Company DescriptionsNational Automation Services OTCMKTS:NESVNational Energy Services, Inc. is a holding company that is engaged in building a portfolio of complementary services through acquisitions. It primarily focuses on drilling services, operation services, and maintenance services of the well-site activities. The company was founded on January 27, 1997 and is headquartered in Las Vegas, NV.Pressure BioSciences OTCMKTS:PBIO$0.0001 0.00 (-66.67%) As of 07/30/2025 01:51 PM EasternPressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.Spectaire NASDAQ:SPEC$0.0003 0.00 (0.00%) As of 08/1/2025Spectaire Holdings Inc. provides solutions that measure, manage, and reduce carbon dioxide equivalent and other greenhouse gas emissions. The company offers AireCore, an integrated hardware, software, and data platform for logistics and supply chain players that uses mass spectrometry to directly measure their emissions. It serves the logistics, energy, agriculture, academics, and indoor air industries. The company is based in Watertown, Massachusetts.Telesis Bio NASDAQ:TBIO$0.02 0.00 (0.00%) As of 08/1/2025Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice, as well as mRNA constructs; and BioXp De Novo kits, which contains building blocks and reagents, including proprietary Gibson assembly branded reagents for specific synthetic biology workflow applications. It also provides BioXp Select kits that offers to use non-telesis bio DNA while using the BioXp system to perform synthetic biology workflow applications, such as cloning, mRNA generation from plasmid, and cell free amplification; BioXp Next Generation Sequencing kits, which contains reagents to go from DNA or RNA to a sequencer-ready library; Benchtop reagents that contains the reagents to proceed specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and custom Gibson short oligo ligation assembly enzymatic DNA synthesis solutions, which is designed to construct synthetic DNA, RNA, and proteins for development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines. The company serves its products to government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022. Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
